Table 2.
Response | Number (%) | 95% confidence interval |
---|---|---|
Complete response | – | – |
Partial response | 20 (60.6) | 48.5–81.8 |
Stable disease | 9 (27.3) | 12.1–45.4 |
Progressive disease | 4 (12.1) | 3.0–30.3 |
Objective response rate | 20 (60.6) | 48.5–81.8 |
Disease control rate | 29 (87.9) | 69.7–97.0 |
Abbreviations: DDP, cisplatin; Nab-PTX, nanoparticle albumin-bound paclitaxel.